AD - Atopisk eksem
Artikel
Patient-Reported Outcome Measures (PROMs) in Dermatology
Interview by DermTalks
DermTalks is a project led with a board of dermatologists and intended to address current challenges, data gaps and emerging trends in dermatology across North-European countries.
Speaker: Prof. Mette Deleuran, Associate Professor and Chair of the Department of Dermatology and Venereology, Aarhus University Hospital, Denmark.
Sleep and QOL: the full impact on patients coping with the burden of AD
Understanding the full scope of AD—the unseen burden on patients.
Atopic dermatitis pathophysiology: type 2 inflammation & cytokines
Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.
Underneath the Skin: Hidden Challenges of Uncontrolled AD and PN
What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?
Advancing Treatment for Uncontrolled AD and PN: New Approaches
As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives8.
Exploring the Unique Characteristics of Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
Explore the distinct clinical manifestations of Atopic Dermatitis (AD) and Prurigo Nodularis (PN), their impact on patients' lives, and the common thread of type 2 inflammation. Understand how these chronic skin conditions differ and intersect in this comprehensive overview.
Begivenhed
Type 2 Inflammation Throughout Life – Live Symposium for HCPs | April 24, 2026
Educational Livestream for Healthcare Professionals April 24, 2026 17:00–18:30 CET.
EADV 2025 with Sanofi: Advanced Dermatology Resources
Discover Sanofi at EADV2025 featuring BioDay registry findings, expert panels, and networking opportunities for dermatology professionals in Paris.
Derma - Academy - Networking & best practice
Holistisk tilgang til patienten med type 2-inflammation.
DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice
3rd of December 2024
DERM 360° - 6th of nov, 2024
Clinical challenges to achieve long-term disease control within treatment of moderate to severe AD.
Leave site modal
Du er ved at forlade campus.sanofi/dk. Sanofi er ikke ansvarlig for indholdet af dette eksterne websted.
Arbejder du inden for sundhedsvæsenet?
Arbejder du inden for sundhedsvæsenet?
Denne hjemmeside indeholder kun information, der er rettet mod sundhedspersoner. Bekræft venligst nedenfor for at modtage information, film, podcasts og andet materiale.